PharmaShots | Incisive News in 3 Shots

Subscribe Now

Transcenta Holding

Transcenta and Agilent Technologies Join Forces for Developing Claudin18.2 Companion Diagnostic to Support the P-III Study of Osemitamab

Transcenta and Agilent Technologies Join Forces for Developing Claudin18.2 Companion Diagnostic to Support the P-III Study of Osem...

April 9, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us